[Basic and clinical studies of pancuronium bromide].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000731:Androstanes / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D003650:Decamethonium Compounds / Q000494:pharmacology; D003964:Diaphragm / Q000187:drug effects; D004558:Electric Stimulation; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D009388:Neostigmine / Q000037:antagonists & inhibitors; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology* / Q000627:therapeutic use; D010791:Phrenic Nerve / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D000731:Androstanes; D003650:Decamethonium Compounds; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D009388:Neostigmine; D013390:Succinylcholine; D014403:Tubocurarine